The 12-month ASHP-accredited oncology pharmacy residency at the University of Colorado Skaggs School of Pharmacy prepares residents for high levels of success.
As a post graduate year 2 (PGY2) program, completion of a PGY1 program is a required prerequisite, consistent with ASHP accreditation.
As part of this program, our residents receive comprehensive experiences in contemporary oncology practice. Residents provide pharmaceutical care to medical oncology patients in both the inpatient and outpatient oncology settings at the University of Colorado Hospital and the University of Colorado Cancer Center. Clinical rotations include stem cell transplant, medical oncology, pediatric oncology, radiation oncology, developmental therapeutics, supportive care and elective experiences. The residency provides experiences and flexibility to satisfy the specific interests of the resident.
Our residents are directed in skills critical to patient care and effective communication through clinical rotations and structured educational sessions. A multidisciplinary approach to patient care is highly emphasized. Residents will also be involved in the education of pharmacy students, through limited didactic teaching and clerkship precepting of pharmacy students, as well as medical residents and other healthcare professionals. This residency requires the development and implementation of a research project and will give the resident writing experience. Oncology preceptors include several experienced clinical practitioners with opportunities to work with research-oriented faculty members.
Upon successful completion of the residency, residents will be able to pursue positions in academics as well as a variety of clinical practice settings.
Ian McVinney grew up in Little Rock, Arkansas and attended Hendrix College, earning his Bachelor of Arts in Chemistry with a minor in Biology. He then attended the University of Arkansas for Medical Sciences College of Pharmacy to get his Doctor of Pharmacy. After completing his degree, he moved to Memphis to complete a PGY1 at Baptist Memorial Hospital - Memphis. He is excited to do his PGY2 training at UC Health in one of his favorite areas of the country! His oncology interests include hematological malignancies and stem cell transplant, but he is excited to grow his knowledge in all aspects of oncology. Outside of work, Ian likes to play tennis, travel, try new restaurants and breweries, and explore the outdoors.
Pharmacy and Pharmaceutical Sciences Building
12850 East Montview Boulevard
First Floor Room 1223
Aurora, CO 80045
Practice site: University of Colorado Cancer Center (UCCC), Anschutz Outpatient Cancer Pavilion. The UCCC is the only National Cancer Institute (NCI)-designated comprehensive cancer center in the Rocky Mountain Region.
Services provided include provision of drug information and education, supportive care management for patients, drug counseling on chemotherapy and investigational agents, toxicity monitoring for patients on phase 1 clinical trials and pharmacy-based chemotherapy-induced anemia clinic.
This is also a rotation site for fourth-year pharmacy students, Pharmacy Practice and Oncology Pharmacy Practice residents.
Clinical research: Serve as Principal Investigator and Co-principal Investigator on Phase 1 and Organ Dysfunction Oncology Clinical Trials.
Areas of interest: Oncology developmental therapeutics, Organ dysfunction, biological correlates associated with molecular targeted agents, chemotherapy dose modification and pharmacy-managed supportive care issues in cancer treatment.